<DOC>
	<DOC>NCT03045445</DOC>
	<brief_summary>Hypothesis: double low-dose protocol provide better lesion conspicuity than standard protocol CT in patients at high-risk of HCC. patients who are scheduled for CECT for HCC diagnosis or surveillance are eligible for this study and allocated to either standard protocol or double-low dose protocol using spectral CT with low radiation dose and low dose of contrast media, within clinically accpetable range.</brief_summary>
	<brief_title>"Double Low-Dose" DECT for HCC Imaging</brief_title>
	<detailed_description />
	<criteria>high risk of HCC (chronic hepatitis B or C, or LC of any cause) signed informed consent scheduled for contrast enhanced liver CT for HCC surveillance or diagnosis no risk factor for HCC history of iodine hypersensitivity renal dysfunction (Estimated GFR &lt; 30mL/min/1.73m2) or on dialysis metformin medication within 48 hours any other contraindication of CECT BMI &gt; or = 30</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>CT</keyword>
	<keyword>dual energy</keyword>
	<keyword>low dose</keyword>
</DOC>